FindMyRecallSubscribe
Class III: unlikely to cause harmOngoing

Avkare Tranexamic Acid Tablets Recall

Tranexamic Acid USP Tablets, 650 mg, 30 tablets (3X10) Unit Dose, Rx Only, Manufactured…

AVKARE LLC · Pulaski, TN

Risk level
Class III
Reported by FDA
Jun 21, 2023
Recall ID
D-0875-2023
Check your lot numberHow we source this data

Summary

Avkare recalled Tranexamic Acid Tablets starting Jun 13, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0875-2023 on Jun 21, 2023. Reason: Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity. Status: Ongoing.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

Product description

Tranexamic Acid USP Tablets, 650 mg, 30 tablets (3X10) Unit Dose, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-772-13

Lot numbers, UPCs & expiration codes

Lot: 44286 Exp. 02/2025

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0875-2023
Classification
Class III
Status
Ongoing
Recall initiated
Jun 13, 2023
FDA report date
Jun 21, 2023
Quantity
592 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
AVKARE LLC

Original FDA data

Every field from FDA enforcement report D-0875-2023, exactly as published.

Show all FDA fields
City
Pulaski
State
TN
Status
Ongoing
Country
United States
Event ID
92535
Address
615 N 1st St
Code information
Lot: 44286 Exp. 02/2025
Postal code
38478-2403
Report date
Jun 21, 2023
Product type
Drugs
Recall number
D-0875-2023
Classification
Class III
Recalling firm
AVKARE LLC
Product quantity
592 cartons
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tranexamic Acid USP Tablets, 650 mg, 30 tablets (3X10) Unit Dose, Rx Only, Manufactured for: AvKARE Pulaski, TN 38478, NDC 50268-772-13
Distribution pattern
Nationwide in the USA.
Recall initiation date
Jun 13, 2023
Initial firm notification
Letter
Center classification date
Jun 15, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0875-2023, published Jun 21, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls